Regulation of adipocyte differentiation and insulin action with rapamycin

Hye Jin Cho1, Jiyoung Park, Hyun Woo Lee

  • 1School of Biological Sciences, Seoul National University, Seoul 151-742, Republic of Korea.

Insights

Rapamycin inhibits adipocyte differentiation and insulin signaling by impacting adipogenesis and lipogenesis. This mTOR inhibitor affects key gene expression and glucose uptake, highlighting mTOR

Area of Science:

  • Cell Biology
  • Metabolism
  • Molecular Endocrinology

Background:

  • Mammalian target of rapamycin (mTOR) is a key regulator of cell growth and metabolism.
  • Adipocyte differentiation (adipogenesis) and insulin signaling are crucial for metabolic homeostasis.
  • The precise role of mTOR in adipogenesis and insulin action requires further elucidation.

Purpose of the Study:

  • To investigate the effects of mTOR inhibition using rapamycin on adipocyte differentiation and insulin signaling.
  • To determine the impact of rapamycin on adipogenesis, lipogenesis, and insulin-dependent glucose uptake.
  • To elucidate the role of mTOR in the execution of adipogenic programming and insulin action.

Main Methods:

  • Utilized 3T3-L1 and 3T3-F442A cell lines for adipogenesis studies.
  • Administered rapamycin to inhibit mTOR signaling.
  • Assessed adipocyte marker gene expression (PPARγ, adipsin, aP2, ADD1/SREBP1c, FAS).
  • Quantified intracellular lipid accumulation.
  • Evaluated insulin-stimulated phosphorylation of AKT and GSK.
  • Measured insulin-dependent glucose uptake.

Main Results:

  • Rapamycin significantly reduced adipocyte marker gene expression and intracellular lipid accumulation in both cell lines.
  • The inhibitory effect of rapamycin on adipogenesis persisted throughout differentiation, not limited to clonal expansion.
  • Chronic rapamycin treatment blunted insulin-stimulated AKT and GSK phosphorylation and reduced glucose uptake in differentiated adipocytes.
  • Constitutive mTOR activation appears necessary for adipogenic programming.

Conclusions:

  • mTOR inhibition by rapamycin impairs adipocyte differentiation by suppressing adipogenesis and lipogenesis.
  • Rapamycin downregulates insulin signaling and glucose uptake in mature adipocytes.
  • mTOR plays a critical role in both adipogenesis and the regulation of insulin action.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...